The FDA has linked Amgen’s vasculitis drug Tavneos to 76 postmarketing cases of drug-induced liver injury, including eight deaths, 54 hospitalizations and 74 serious outcomes. Seven patients developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results